Le Lézard
Classified in: Health, Business
Subjects: ERN, CCA

PharmaCielo to Hold Conference Call to Review Second Quarter 2020 Financial Results


TORONTO and RIONEGRO, Colombia, Aug. 18, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that it will host a conference call on Monday, August 31st, 2020, at 8:30 a.m. ET to discuss its second quarter financial results and provide investors with key business highlights. The call will be chaired by David Attard, CEO, Henning Von Koss, President, David Gordon, CCO and Scott Laitinen, CFO.

CONFERENCE CALL DETAILS

Date: August 31st, 2020 | Time: 8:30am ET

Participant Dial-in: 416-764-8650 or 1-888-664-6383

Replay Dial-in: 416-764-8677 or 1-888-390-0541

Conference ID: 11880297

Playback #: 880297  (Expires September 14th, 2020)

Listen to webcast: event.on24.com

About PharmaCielo
PharmaCielo Ltd. (TSXV: PCLO, OTCQX: PCLOF) is a global company, headquartered in Canada, with a focus on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal (and wholly owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its cultivation and processing centre located in Rionegro, Colombia.

The board of directors and executive team of PharmaCielo are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise. PharmaCielo recognized the significant role that Colombia's ideal location plays in building a sustainable business in the medical cannabis industry, and the Company, together with its directors and executives, is executing on a business plan focused on supplying the international marketplace.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PharmaCielo Ltd.


These press releases may also interest you

at 18:00
Patagonia Gold Corp. ("Patagonia" or the "Company") announces its audited results for the financial year ended December 31, 2023 ("YE 2023"). The audited consolidated financial statements for YE 2023, together with the related management's...

at 17:50
SIRIOS RESOURCES SIRIOS INC. (the "Corporation") announces the completion of the second and final tranche of its previously announced non-brokered private placement, for additional gross proceeds of $380,750 (the "Offering") through the issuance of...

at 17:50
US Metro Bancorp : US Metro Bancorp ("Bancorp") is a bank holding company, with a single subsidiary, US Metro Bank ("Bank"). On a consolidated basis, the Bancorp earned $1.5 million in the first quarter of 2024, compared to $2.5 million in the fourth...

at 17:50
Today, the Alberta government announced a consultation on auto insurance system reform, releasing two reports that examine potential options. The reports are from consulting firms Oliver Wyman (OW) and Nous Group. Following the release of the...

at 17:41
We are advised by a representative for FirstHive that journalists and other readers should disregard the news release, FirstHive Welcomes Investors Benhamou Global Ventures, Saama and Amit Singal in New Funding Round, issued April 24, 2024 over PR...

at 17:30
The global insurance market size is estimated to grow by USD 1.42 billion from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of 4.5% during the forecast period. ...



News published on and distributed by: